Clinical trials in the U.K., Brazil, India and South Africa resumed after the drugmaker paused them following a volunteer's “unexplained illness.”
MarketWatch.com - Top Stories, MarketWatch
Thu, 10/01/2020 - 4:39am
Clinical trials in the U.K., Brazil, India and South Africa resumed after the drugmaker paused them following a volunteer's “unexplained illness.”